Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Proteomics ; 3(3): 299-306, 2003 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-12627383

RESUMEN

Recently we investigated the influence of classical and emerging antibiotics on the proteome of Bacillus subtilis including in our studies actinonin, a potent novel inhibitor of peptide deformylase. The protein synthesis pattern under actinonin treatment changed so dramatically that a direct comparison to the control pattern was impossible. Dual channel imaging revealed that actinonin treatment caused the majority of newly synthesised proteins to accumulate in spots different from the ones usually observed, indicating a more acidic isoelectric point. Two strategies were used to investigate the nature of the charge shift. In the first place, protein patterns of a conditional peptide deformylase mutant under nonrepressing and repressing conditions were compared. Secondly, several protein pairs excised from two-dimensional (2-D) gels of the peptide deformylase mutant, exponentially growing untreated wild-type and the actinonin treated wild-type were investigated with matrix-assisted laser desorption/ionization and electrospray ionization (ESI) time of flight mass spectrometry (TOF MS) for the existence of N-terminal formylation. Under nonrepressing conditions the mutant protein pattern resembled that of the wild-type. The loss of peptide deformylase activity under repressing conditions led to the same pI shift observed for actinonin treatment in the wild-type. Quadrupole TOF-MS on 11 protein pairs proved that the remaining N-terminal formyl residue was indeed responsible for the charge shift. Eight of these protein pairs were also present on 2-D gels of exponentially growing B. subtilis, where the more acidic, still formylated protein species represented the smaller parts.


Asunto(s)
Amidohidrolasas/fisiología , Proteínas Bacterianas/biosíntesis , Proteínas Bacterianas/química , Secuencia de Aminoácidos , Antibacterianos/farmacología , Bacillus subtilis/metabolismo , Citosol/metabolismo , Electroforesis en Gel Bidimensional , Ácidos Hidroxámicos/farmacología , Punto Isoeléctrico , Espectrometría de Masas , Datos de Secuencia Molecular , Mutación , Péptidos/química , Estructura Terciaria de Proteína , Proteoma , Espectrometría de Masa por Ionización de Electrospray , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Factores de Tiempo
2.
Antimicrob Agents Chemother ; 47(3): 948-55, 2003 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-12604526

RESUMEN

We have used proteomic technology to elucidate the complex cellular responses of Bacillus subtilis to antimicrobial compounds belonging to classical and emerging antibiotic classes. We established on two-dimensional gels a comprehensive database of cytoplasmic proteins with pIs covering a range of 4 to 7 that were synthesized during treatment with antibiotics or agents known to cause generalized cell damage. Although each antibiotic showed an individual protein expression profile, overlaps in the expression of marker proteins reflected similarities in molecular drug mechanisms, suggesting that novel compounds with unknown mechanisms of action may be classified. Indeed, one such substance, a structurally novel protein synthesis inhibitor (BAY 50-2369), could be classified as a peptidyltransferase inhibitor. These results suggest that this technique gives new insights into the bacterial response toward classical antibiotics and hints at modes of action of novel compounds. Such a method should prove useful in the process of antibiotic drug discovery.


Asunto(s)
Antibacterianos/farmacología , Bacillus subtilis/efectos de los fármacos , Proteómica , Antiinfecciosos Urinarios/farmacología , Proteínas Bacterianas/química , Proteínas Bacterianas/efectos de los fármacos , Dermatoglifia del ADN , Electroforesis en Gel de Poliacrilamida , Procesamiento de Imagen Asistido por Computador , Marcaje Isotópico , Metionina/metabolismo , Nitrofurantoína/farmacología , Pirimidinonas/farmacología , Radioisótopos de Azufre
3.
J Bacteriol ; 184(2): 459-67, 2002 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11751823

RESUMEN

Low concentrations of the RNA polymerase inhibitor rifampin added to an exponentially growing culture of Bacillus subtilis led to an instant inhibition of growth. Survival experiments revealed that during the growth arrest the cells became tolerant to the antibiotic and the culture was able to resume growth some time after rifampin treatment. L-[(35)S]methionine pulse-labeled protein extracts were separated by two-dimensional polyacrylamide gel electrophoresis to investigate the change in the protein synthesis pattern in response to rifampin. The sigma(B)-dependent general stress proteins were found to be induced after treatment with the antibiotic. Part of the oxidative stress signature was induced as indicated by the catalase KatA and MrgA. The target protein of rifampin, the beta subunit (RpoB) of the DNA-dependent RNA polymerase, and the flagellin protein Hag belonging to the sigma(D) regulon were also induced. The rifampin-triggered growth arrest was extended in a sigB mutant in comparison to the wild-type strain, and the higher the concentration, the more pronounced this effect was. Activity of the RsbP energy-signaling phosphatase in the sigma(B) signal transduction network was also important for this protection against rifampin, but the RsbU environmental signaling phosphatase was not required. The sigB mutant strain was less capable of growing on rifampin-containing agar plates. When plated from a culture that had already reached stationary phase without previous exposure to the antibiotic during growth, the survival rate of the wild type exceeded that of the sigB mutant by a factor of 100. We conclude that the general stress response of B. subtilis is induced by rifampin depending on RsbP activity and that loss of SigB function causes increased sensitivity to the antibiotic.


Asunto(s)
Bacillus subtilis/efectos de los fármacos , Proteínas Bacterianas/metabolismo , ARN Polimerasas Dirigidas por ADN/antagonistas & inhibidores , Inhibidores Enzimáticos/farmacología , Rifampin/farmacología , Factor sigma/metabolismo , Agar , Bacillus subtilis/genética , Bacillus subtilis/crecimiento & desarrollo , Bacillus subtilis/metabolismo , Proteínas Bacterianas/genética , Proteínas Portadoras/genética , Medios de Cultivo , Relación Dosis-Respuesta a Droga , Farmacorresistencia Bacteriana , Electroforesis en Gel Bidimensional/métodos , Estrés Oxidativo , Factor sigma/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...